101 related articles for article (PubMed ID: 2281197)
1. Decrease of catecholamine and neuropeptide Y-like immunoreactivity in the glycerol-induced acute renal failure of rats.
Cheng JT; Shen CL; Huang JJ
Res Exp Med (Berl); 1990; 190(5):315-22. PubMed ID: 2281197
[TBL] [Abstract][Full Text] [Related]
2. Effects of vinblastine on neuropeptide Y levels in the sympathoadrenal system, bone marrow and thrombocytes of the rat.
Hemsén A; Pernow J; Millberg BI; Lundberg JM
Agents Actions; 1991 Nov; 34(3-4):429-38. PubMed ID: 1810152
[TBL] [Abstract][Full Text] [Related]
3. Alterations in circulating levels and cardiovascular tissue content of neuropeptide Y-like immunoreactivity during the development of deoxycorticosterone acetate-salt hypertension in the rat.
Moreau P; de Champlain J; Yamaguchi N
J Hypertens; 1992 Aug; 10(8):773-80. PubMed ID: 1325509
[TBL] [Abstract][Full Text] [Related]
4. Increase of plasma neuropeptide Y-like immunoreactivity following chronic hypoxia in the rat.
Cheng JT; Chen CF; Shum AY; Wang JY; Chen HI
Neurosci Lett; 1992 Jun; 140(2):211-4. PubMed ID: 1501780
[TBL] [Abstract][Full Text] [Related]
5. Release and vasoconstrictor effects of neuropeptide Y in relation to non-adrenergic sympathetic control of renal blood flow in the pig.
Pernow J; Lundberg JM
Acta Physiol Scand; 1989 Aug; 136(4):507-17. PubMed ID: 2571235
[TBL] [Abstract][Full Text] [Related]
6. [Protection afforded by a novel K channel opener (Y-26763), against glycerol-induced acute renal failure (ARF) in rats].
Okada H; Kobayashi S; Ikeda T
Nihon Jinzo Gakkai Shi; 1997 Jul; 39(5):464-9. PubMed ID: 9283211
[TBL] [Abstract][Full Text] [Related]
7. d-Amphetamine-induced increase in neurotensin and neuropeptide Y outflow in the ventral striatum is mediated via stimulation of dopamine D1 and D2/3 receptors.
Gruber SH; Nomikos GG; Mathé AA
J Neurosci Res; 2002 Jul; 69(1):133-9. PubMed ID: 12111825
[TBL] [Abstract][Full Text] [Related]
8. Renal sympathetic nerve activation in relation to reserpine-induced depletion of neuropeptide Y in the kidney of the rat.
Pernow J; Thorén P; Millberg BI; Lundberg JM
Acta Physiol Scand; 1988 Sep; 134(1):53-9. PubMed ID: 3239423
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide Y: presence in perivascular noradrenergic neurons and vasoconstrictor effects on skeletal muscle blood vessels in experimental animals and man.
Pernow J; Ohlén A; Hökfelt T; Nilsson O; Lundberg JM
Regul Pept; 1987 Dec; 19(5-6):313-24. PubMed ID: 3438489
[TBL] [Abstract][Full Text] [Related]
10. Role of PPAR-gamma on the pathogenesis and vascular changes in glycerol-induced acute renal failure.
Newaz M; Yousefipour Z; Oyekan A
Pharmacol Res; 2006 Sep; 54(3):234-40. PubMed ID: 16820301
[TBL] [Abstract][Full Text] [Related]
11. Ciglitazone, a peroxisome proliferator-activated receptor gamma inducer, ameliorates renal preglomerular production and activity of angiotensin II and thromboxane A2 in glycerol-induced acute renal failure.
Yousefipour Z; Hercule H; Truong L; Oyekan A; Newaz M
J Pharmacol Exp Ther; 2007 Aug; 322(2):461-8. PubMed ID: 17494862
[TBL] [Abstract][Full Text] [Related]
12. Alterations in neuropeptide Y, tyrosine hydroxylase, and Y-receptor subtype distribution following spinal nerve injury to rats.
Marchand JE; Cepeda MS; Carr DB; Wurm WH; Kream RM
Pain; 1999 Feb; 79(2-3):187-200. PubMed ID: 10068164
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-6 stimulates tubular regeneration in rats with glycerol-induced acute renal failure.
Homsi E; Ribeiro-Alves MA; Lopes de Faria JB; Dias EP
Nephron; 2002 Sep; 92(1):192-9. PubMed ID: 12187102
[TBL] [Abstract][Full Text] [Related]
14. Comparative effects of dopexamine and dopamine on glycerol-induced acute renal failure in rats.
Gömez-Garre DN; López-Farré A; Eleno N; López-Novoa JM
Ren Fail; 1996 Jan; 18(1):59-68. PubMed ID: 8820501
[TBL] [Abstract][Full Text] [Related]
15. Paradoxical decrease in circulating neuropeptide Y-like immunoreactivity during mild orthostatic stress in subjects with and without congestive heart failure.
Derchi G; Dupuis J; de Champlain J; Rouleau JL
Eur Heart J; 1993 Jan; 14(1):34-9. PubMed ID: 8432288
[TBL] [Abstract][Full Text] [Related]
16. Studies on colocalization of neuropeptide Y, vasoactive intestinal polypeptide, catecholamine-synthesizing enzymes and acetylcholinesterase in the larynx of the rat.
Domeij S; Dahlqvist A; Forsgren S
Cell Tissue Res; 1991 Mar; 263(3):495-505. PubMed ID: 1678988
[TBL] [Abstract][Full Text] [Related]
17. Na intake, renal renin, and the severity of myohemoglobinuric renal failure in rats.
Bidani AK; Churchill PC
Am J Physiol; 1981 Jul; 241(1):F34-8. PubMed ID: 7018268
[TBL] [Abstract][Full Text] [Related]
18. Evidence for co-transmitter role of neuropeptide Y in the pig spleen.
Lundberg JM; Rudehill A; Sollevi A; Hamberger B
Br J Pharmacol; 1989 Mar; 96(3):675-87. PubMed ID: 2566349
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of reserpine and 6-hydroxydopamine on neuropeptide Y (NPY) and noradrenaline in peripheral neurons.
Lundberg JM; Saria A; Franco-Cereceda A; Hökfelt T; Terenius L; Goldstein M
Naunyn Schmiedebergs Arch Pharmacol; 1985 Jan; 328(3):331-40. PubMed ID: 2858824
[TBL] [Abstract][Full Text] [Related]
20. The synthesis of NPY and DBH is independently regulated in adrenergic nerves after reserpine.
Dahlström A; Bööj S; Goldstein M; Larsson PA
Neurochem Res; 1987 Mar; 12(3):221-5. PubMed ID: 2438565
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
